हिंदी में पढ़ें

Sanofi

Sanofi to invest Euro 400 million in its Hyderabad GCC by 2030

Sanofi to invest Euro 400 million in its Hyderabad GCC by 2030

Wed, Jul 17, 2024

Sanofi Healthcare India Pvt Ltd announced the expansion of its Global Capacity Centre (GCC) here with plans to invest Euro 400 million over the next six years, out of which Euro 100 million will be pumped in by next year.

Drug-maker Lupin completes acquisition of two brands from Sanofi

Drug-maker Lupin completes acquisition of two brands from Sanofi

Wed, Jun 05, 2024

Shares of Lupin were trading 3.21 per cent higher at Rs 1,613.45 apiece on the BSE.

Drugmaker Sanofi partners OpenAI, Formation Bio on AI-powered drug development

Drugmaker Sanofi partners OpenAI, Formation Bio on AI-powered drug development

Tue, May 21, 2024

The companies will bring together data, software and tuned models to create custom, purpose-built solutions across the drug development lifecycle.

TRENDING NOW

Sanofi looks for accelerated growth in India; plans fast-tracking of product pipeline

Sanofi looks for accelerated growth in India; plans fast-tracking of product pipeline

Sun, Apr 07, 2024

The company plans to enhance its presence in the diabetes segment and grow its consumer healthcare business after spinning it off into a new entity while also looking at local production of its various best-in-class products in India.

Encube to acquire Soframycin in India, Sri Lanka for Rs 125 cr

Encube to acquire Soframycin in India, Sri Lanka for Rs 125 cr

Fri, Nov 26, 2021

Encube Ethicals announced that it will be acquiring the skin cream and associated brands for the Indian and Sri Lankan market for a consideration of Rs 125 crore.

Sanofi share price hits 52-week high on Q4 results

Sanofi share price hits 52-week high on Q4 results

Wed, Feb 26, 2020

Shares of pharma company Sanofi India gained as much as 9 per cent and hit its 52-week high of Rs 7,250 on BSE after the company posted strong December quarter result.

Johnson & Johnson to buy Actelion for $30 billion, spin off R&D unit

Johnson & Johnson to buy Actelion for $30 billion, spin off R&D unit

Thu, Jan 26, 2017

The acquisition gives J&J access to the Swiss group`s line-up of high-price, high-margin medicines for rare diseases, helping it diversify its drug portfolio as its biggest product, Remicade for arthritis, faces cheaper competition.

Sanofi, Google launch diabetes joint venture

Sanofi, Google launch diabetes joint venture

Mon, Sep 12, 2016

Google and French pharmaceutical giant Sanofi have announced a new joint venture focused on diabetes care. The tie up between the drug maker and Verily, the health subsidiary of Google`s parent company Alphabet, will focus on treatments for people living with the chronic disease.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x